Okay, let's tackle this question about non-hepatotoxic anti-tubercular drugs. The user wants a detailed explanation following specific formatting. First, I need to recall which anti-TB drugs are known for hepatotoxicity and which aren't.

The core concept here is the hepatotoxic potential of various anti-tubercular drugs. Commonly, drugs like isoniazid, rifampin, pyrazinamide, and ethambutol are part of first-line therapy. Among these, isoniazid and pyrazinamide are notorious for causing liver damage. Rifampin is also implicated, though maybe less so. Ethambutol is generally safer in that aspect. Then there are other drugs like streptomycin, which is an aminoglycoside, and maybe newer ones like linezolid or bedaquiline, but those have their own side effects.

The correct answer should be a drug that's part of the anti-TB regimen but doesn't cause liver toxicity. Let me check: ethambutol is known for optic neuritis but not hepatotoxicity. Streptomycin causes ototoxicity and nephrotoxicity. So between the options given, if the correct answer is ethambutol (assuming option C is ethambutol), then that's the right choice. But the user's correct answer placeholder is missing, so I need to infer based on standard options. Typically, in such questions, ethambutol is the non-hepatotoxic one. Let's confirm that.

Now, the wrong options would include isoniazid, rifampin, pyrazinamide—all known to cause hepatotoxicity. So if the options are A: Isoniazid, B: Rifampin, C: Ethambutol, D: Pyrazinamide, then the correct answer is C.

In the explanation, the core concept is the hepatotoxicity of various anti-TB drugs. The correct answer is ethambutol because it doesn't cause liver damage. The other options are incorrect because they are associated with hepatotoxicity. The clinical pearl would be to remember that the "RIP" (Rifampin, Isoniazid, Pyrazinamide) drugs are the ones to watch for liver issues, while ethambutol's main side effect is optic neuritis.

Make sure the explanation is concise, fits within the character limit, and follows the required sections. Also, check that each section is properly labeled and the key terms are bolded. Avoid markdown except for bold and sections. Let me structure the explanation accordingly.

**Core Concept**
Hepatotoxicity is a critical adverse effect of several first-line anti-tubercular drugs. **Isoniazid**, **pyrazinamide**, and **rifampin** are well-known for causing liver injury, while **ethambutol** is notable for optic neuritis but not hepatotoxicity.

**Why the Correct Answer is Right**
**Ethambutol** is a bacteriostatic anti-tubercular agent that inhibits arabinogalactan synthesis in *Mycobacterium tuberculosis*. It lacks the metabolic pathways or mechanisms that induce hepatic damage. Its primary adverse effect is dose-dependent optic neuropathy (leading to red-green color blindness), not liver toxicity. This makes it a safer option in

✓ Correct Answer: D. Ethambutol